| Primary |
| Essential Hypertension |
24.1% |
| Atrial Fibrillation |
8.6% |
| Acute Myocardial Infarction |
6.9% |
| Asthma |
5.2% |
| Hypertension |
5.2% |
| Myocardial Ischaemia |
5.2% |
| Prophylactic |
5.2% |
| Acute Pain |
3.4% |
| Atrial Flutter |
3.4% |
| Chronic Renal Failure |
3.4% |
| Depression |
3.4% |
| Dyspepsia |
3.4% |
| Ex-tobacco User |
3.4% |
| Heart Valve Replacement |
3.4% |
| Pulmonary Embolism |
3.4% |
| Simple Partial Seizures |
3.4% |
| Type 2 Diabetes Mellitus |
3.4% |
| Acute Endocarditis |
1.7% |
| Antiplatelet Therapy |
1.7% |
| Anxiety Disorder |
1.7% |
|
| Subarachnoid Haemorrhage |
11.5% |
| Cerebral Haemorrhage |
7.7% |
| Haemorrhage Intracranial |
7.7% |
| Renal Failure Chronic |
7.7% |
| Urticaria |
7.7% |
| Cerebellar Haemorrhage |
3.8% |
| Colitis |
3.8% |
| Epistaxis |
3.8% |
| Left Ventricular Failure |
3.8% |
| Malaise |
3.8% |
| Medication Error |
3.8% |
| Melaena |
3.8% |
| Myocardial Ischaemia |
3.8% |
| Neutrophil Count Decreased |
3.8% |
| Orthostatic Hypotension |
3.8% |
| Pancytopenia |
3.8% |
| Pemphigus |
3.8% |
| Peritoneal Haemorrhage |
3.8% |
| Potentiating Drug Interaction |
3.8% |
| Premature Baby |
3.8% |
|
| Secondary |
| Product Used For Unknown Indication |
34.3% |
| Essential Hypertension |
17.1% |
| Type 2 Diabetes Mellitus |
5.7% |
| Atrial Fibrillation |
3.8% |
| Benign Prostatic Hyperplasia |
3.8% |
| Gastrooesophageal Reflux Disease |
3.8% |
| Hypercholesterolaemia |
3.8% |
| Iron Deficiency |
3.8% |
| Gout |
2.9% |
| Pulmonary Embolism |
2.9% |
| Atrial Flutter |
1.9% |
| Bipolar Disorder |
1.9% |
| Cerebral Infarction |
1.9% |
| Depression |
1.9% |
| Depressive Symptom |
1.9% |
| Drug Use For Unknown Indication |
1.9% |
| Metastatic Malignant Melanoma |
1.9% |
| Pain |
1.9% |
| Thrombosis Prophylaxis |
1.9% |
| Anaemia |
1.0% |
|
| Pemphigus |
12.5% |
| Rash |
9.4% |
| Renal Failure Acute |
9.4% |
| Somnolence |
9.4% |
| Melaena |
6.3% |
| Pancreatitis |
6.3% |
| Premature Baby |
6.3% |
| Cerebral Haemorrhage |
3.1% |
| Drug Interaction |
3.1% |
| Gastric Ulcer |
3.1% |
| Haemorrhagic Anaemia |
3.1% |
| Hypertension |
3.1% |
| Malaise |
3.1% |
| Maternal Exposure During Pregnancy |
3.1% |
| Medication Error |
3.1% |
| Orthostatic Hypotension |
3.1% |
| Renal Failure Chronic |
3.1% |
| Speech Disorder |
3.1% |
| Syncope |
3.1% |
| Therapeutic Response Increased |
3.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
34.5% |
| Myocardial Ischaemia |
9.7% |
| Essential Hypertension |
6.9% |
| Pain |
6.9% |
| Drug Use For Unknown Indication |
6.1% |
| Hypertensive Heart Disease |
3.6% |
| Hypertension |
3.3% |
| Type 2 Diabetes Mellitus |
3.3% |
| Plasma Cell Myeloma |
3.0% |
| Insomnia |
2.8% |
| Depression |
2.5% |
| Prophylaxis |
2.5% |
| Acute Myocardial Infarction |
2.2% |
| Pelvic Fracture |
2.2% |
| Atrial Fibrillation |
1.9% |
| Schizophrenia |
1.9% |
| Oesophageal Carcinoma |
1.7% |
| Pneumonia Bacterial |
1.7% |
| Psoriasis |
1.7% |
| Rheumatoid Arthritis |
1.7% |
|
| Renal Failure Acute |
15.2% |
| Renal Failure Chronic |
10.6% |
| Pyrexia |
6.1% |
| Syncope |
6.1% |
| Myalgia |
4.5% |
| Overdose |
4.5% |
| Pain |
4.5% |
| Rhabdomyolysis |
4.5% |
| Systemic Lupus Erythematosus |
4.5% |
| Thrombocytopenia |
4.5% |
| Toxicity To Various Agents |
4.5% |
| Ventricular Tachycardia |
4.5% |
| Weight Decreased |
4.5% |
| Completed Suicide |
3.0% |
| Coronary Artery Thrombosis |
3.0% |
| Delirium |
3.0% |
| Eosinophilic Pneumonia |
3.0% |
| Fall |
3.0% |
| Hepatocellular Injury |
3.0% |
| Hyponatraemia |
3.0% |
|
| Interacting |
| Acute Myocardial Infarction |
13.0% |
| Atrial Fibrillation |
13.0% |
| Cerebrovascular Accident Prophylaxis |
8.7% |
| Essential Hypertension |
8.7% |
| Hip Arthroplasty |
6.5% |
| Product Used For Unknown Indication |
6.5% |
| Atrial Flutter |
4.3% |
| Constipation |
4.3% |
| Dysthymic Disorder |
4.3% |
| Insomnia |
4.3% |
| Myocardial Infarction |
4.3% |
| Pulmonary Embolism |
4.3% |
| Anticoagulant Therapy |
2.2% |
| Embolism Venous |
2.2% |
| Gastric Ulcer |
2.2% |
| Hypercholesterolaemia |
2.2% |
| Hypothyroidism |
2.2% |
| Metabolic Disorder |
2.2% |
| Myocardial Ischaemia |
2.2% |
| Pain |
2.2% |
|
| Drug Interaction |
23.1% |
| Pulmonary Embolism |
15.4% |
| Haemoptysis |
7.7% |
| Hypertension |
7.7% |
| Melaena |
7.7% |
| Occult Blood Positive |
7.7% |
| Syncope |
7.7% |
| Thrombocytopenia |
7.7% |
| Tongue Haematoma |
7.7% |
| Tremor |
7.7% |
|
